Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse

Journal of Clinical Immunology

Volumn 29, Issue 5, 2009, Pages 646-656

  Reynolds, Jessica L ^a   Mahajan, Supriya D ^a   Aalinkeel, Ravikunar ^a   Nair, Bindukumar ^a   Sykes, Donald E ^a   Agosto Mujica, Anardi ^a   Hsiao, Chiu Bin ^a   Schwartz, Stanley A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cocaine; Difference gel electrophoresis (DIGE); High performance liquid chromatography tandem mass spectrometry (HPLC MS MS); Human immunodeficiency virus type 1 (HIV 1); Methamphetamine; Peripheral blood mononuclear cells (PBMC)

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; BETA GLOBIN; CALPAIN; CALPONIN 2; COCAINE; ERYTHROCYTE BAND 7 INTEGRAL MEMBRANE PROTEIN; FIBRINOGEN GAMMA CHAIN; GALECTIN 1; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; LACTATE DEHYDROGENASE; METHAMPHETAMINE; PEROXIREDOXIN 6; POLY(RC) BINDING PROTEIN 1; PROTEIN DERIVATIVE; PROTEOME; PROTEOME ALPHA1; PROTEOME ALPHA3; RHO GDP DISSOCIATION INHIBITOR ALPHA; RHO GDP DISSOCIATION INHIBITOR BETA; RNA BINDING PROTEIN REGULATORY SUBUNIT; SUPEROXIDE DISMUTASE; TALIN 1; TRANSGELIN 2; TUBULIN; TUMOR PROTEIN D54; TYROSINE 3 MONOOXYGENASE TRYPTOPHAN 5 MONOOXYGENASE ACTIVATION PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; B LYMPHOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG ABUSE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; METHAMPHETAMINE; POLYMERASE CHAIN REACTION; PROTEOME; SUBSTANCE-RELATED DISORDERS;

EID: 69249221277     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9309-5     Document Type: Article

References (54)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2006 ( www.avert.org/statsum.htm )
2. A Nath WF Maragos MJ Avison FA Schmitt JR Berger 2001 Acceleration of HIV dementia with methamphetamine and cocaine J Neurovirol 7 1 66 71
3. H Mohri Me Markowitz 2008 In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progression J Acquir Immune Defic Syndr 48 5 511 521
4. R Duncan P Shapshak JB Page F Chiappelli CB McCoy SE Messiah 2007 Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women Front Biosci 12 1488 1495
5. JA Cook JK Burke-Miller MH Cohen RL Cook D Vlahov TE Wilson ET Golub RM Schwartz AA Howard C Ponath MW Plankey AM Levine DD Grey 2008 Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women AIDS 22 11 1355 1363
6. PK Peterson G Gekker R Schut S Hu HH Balfour Jr CC Chao 1993 Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection Adv Exp Med Biol 335 181 188
7. PK Peterson G Gekker CC Chao R Schut TW Molitor HH Balfour Jr 1991 Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta J Immunol 146 1 81 84
8. MP Nair SD Mahajan SA Schwartz J Reynolds R Whitney Z Bernstein RP Chawda D Sykes R Hewitt CB Hsiao 2005 Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients J Immunol 174 11 6617 6626
9. JL Reynolds SD Mahajan DE Sykes SA Schwartz 2007 Nair MP Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC) Biochim Biophys Acta 1774 4 433 442
10. H Liang X Wang H Chen L Song L Ye SH Wang YJ Wang L Zhou WZ Ho 2008 Methamphetamine enhances HIV infection of macrophages Am J Pathol 172 6 1617 1624
11. RJ Ellis ME Childers M Cherner D Lazzaretto S Letendre I Grant 2003 Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy J Infect Dis 188 1820 1826
12. ER Cachay N Moini SL Kosakovsky Pond R Pesano YS Lie H Aiem DM Butler S Letendre WC Mathews DM Smith 2007 Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration Open AIDS J 1 5 10
13. YW Lee B Hennig J Yao M Toborek 2001 Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells J Neurosci Res 66 583 591
14. Z Tallóczy J Martinez D Joset Y Ray A Gácser S Toussi N Mizushima J Nosanchuk H Goldstein J Loike D Sulzer L Santambrogio 2008 Methamphetamine inhibits antigen processing, presentation, and phagocytosis PLoS Pathog 4 2 e28
15. DJ Edwards SK Bowles 1988 Protein binding of cocaine in human serum Pharm Res 5 440 442
16. T Takayasu T Ohshima J Nishigami T Kondo T Nagaon 1995 Screening and determination of methamphetamine and amphetamine in the blood, urine and stomach contents in emergency medical care and autopsy cases J Clin Forensic Med 2 25 33
17. KS Kalasinsky TZ Bosy GA Schmunk G Reiber RM Anthony Y Furukawa M Guttman SJ Kish 2001 Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users Forensic Sci Int 116 163 169
18. RJF Schepers JM Oyler RE Joseph EJ Cone ET Moolchan MA Huestis 2003 Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers Clin Chem 49 121 132
19. D Wessel UI Flügge 1984 A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids Anal Biochem 138 1 141 143
20. L Breci E Hattrup M Keeler J Letarte R Johnson PA Haynes 2005 Comprehensive proteomics in yeast using chromatographic fractionation, gas phase fractionation, protein gel electrophoresis, and isoelectric focusing Proteomics 5 8 2018 2028
21. F Gharahdaghi CR Weinberg DA Meagher BS Imai SM Mische 1999 Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity Electrophoresis 20 3 601 605
22. B Cooper D Eckert NL Andon JR Yates PA Haynes 2003 Investigative proteomics: identification of an unknown plant virus from infected plants using mass spectrometry J Am Soc Mass Spectrom 14 7 736 741
23. M Wilm A Shevchenko T Houthaeve S Breit L Schweigerer T Fotsis M Mann 1996 Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry Nature 379 6564 466 469
24. PA Haynes SP Gygi D Figeys R Aebersold 1998 Proteome analysis: biological assay or data archive? Electrophoresis 19 11 1862 1871
25. NL Andon S Hollingworth A Koller AJ Greenland JR Yates 3rd PA Haynes 2002 Proteomic characterization of wheat amyloplasts using identification of proteins by tandem mass spectrometry Proteomics 2 9 1156 1168
26. P Chomczynski N Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1 156 159
27. L Shively L Chang JM LeBon Q Liu AD Riggs J Singer-Sam 2003 Real-time PCR assay for quantitative mismatch detection Biotechniques 34 498 502
28. Z Prohászka G Füst 2004 Immunological aspects of heat-shock proteins-the optimum stress of life Mol Immunol 41 1 29 44
29. CA Gullo G Teoh 2004 Heat shock proteins: to present or not, that is the question Immunol Lett 94 1-2 1 10
30. Z Wainberg M Oliveira S Lerner Y Tao BG Brenner 1997 Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1 Virology 233 364 373
31. C Gurer A Cimarelli J Luban 2002 Specific incorporation of heat shock protein 70 family members into primate lentiviral virions J Virol 76 4666 4670
32. I Agostini S Popov J Li L Dubrovsky T Hao M Bukrinsky 2000 Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex Exp Cell Res 259 398 403
33. S Iordanskiy Y Zhao L Dubrovsky T Iordanskaya M Chen D Liang M Bukrinsky 2004 Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R J Virol 78 9697 9704
34. S Iordanskiy Y Zhao P DiMarzio I Agostini L Dubrovsky M Bukrinsky 2004 Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages Blood 104 1867 1872
35. N Wang D Stamenovic 2002 Mechanics of vimentin intermediate filaments J Muscle Res Cell Motil 23 5-6 535 540
36. J Snásel R Shoeman M Horejsí O Hrusková- Heidingsfeldová J Sedlácek T Ruml I Pichová 2000 Cleavage of vimentin by different retroviral proteases Arch Biochem Biophys 377 2 241 245
37. B Höner RL Shoeman P Traub 1991 Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture J Cell Sci 100 Pt 4 799 807
38. B Höner RL Shoeman P Traub 1992 Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease Cell Biol Int Rep 16 7 603 612
39. RL Shoeman B Höner TJ Stoller C Kesselmeier MC Miedel P Traub MC Graves 1990 Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein Proc Natl Acad Sci U S A 87 16 6336 6340
40. RL Shoeman C Hüttermann R Hartig P Traub 2001 Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells Mol Biol Cell 12 1 143 154
41. MK Karczewski K Strebel 1996 Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein J Virol 70 1 494 507
42. T Henzler A Harmache H Herrmann H Spring M Suzan G Audoly T Panek V Bosch 2001 Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure J Gen Virol 82 Pt 3 561 573
43. CB Pocernich D Boyd-Kimball HF Poon V Thongboonkerd BC Lynn JB Klein V Calebrese A Nath DA Butterfield 2005 Proteomics analysis of human astrocytes expressing the HIV protein Tat Brain Res Mol Brain Res 133 2 307 316
44. R Geiben-Lynn M Kursar NV Brown MM Addo H Shau J Lieberman AD Luster BD Walker 2003 HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family J Biol Chem 278 3 1569 1574
45. EM Ross 2008 Coordinating speed and amplitude in G-protein signaling Curr Biol 18 17 R777 783
46. TS Stantchev CC Broder 2001 Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors Cytokine Growth Factor Rev 12 2-3 219 243
47. G Audoly MR Popoff P Gluschankof 2005 Involvement of a small GTP binding protein in HIV-1 release Retrovirology 2 4
48. YL Lin C Mettling P Portalès B Réant J Clot P Corbeau 2005 G-protein signaling triggered by R5 human immunodeficiency virus type 1 increases virus replication efficiency in primary T lymphocytes J Virol 79 12 7938 7941
49. BO Ibeh O Obidoa PN Uzoegwu 2008 High plasma activity of endogenous antioxidants protect CD4+ T-cells in HIV-serodiscordant heterosexual partners in a Nigerian population Int J STD AIDS 19 8 536 540
50. L Agrawal JP Louboutin BA Reyes EJ Van Bockstaele DS Strayer 2006 Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis Gene Ther 13 23 1645 1656
51. MT Elola C Wolfenstein-Todel MF Troncoso GR Vasta GA Rabinovich 2007 Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival Cell Mol Life Sci 64 13 1679 1700
52. MT Elola ME Chiesa AF Alberti J Mordoh NE Fink 2005 Galectin-1 receptors in different cell types J Biomed Sci 12 1 13 29
53. S Mercier C St-Pierre I Pelletier M Ouellet MJ Tremblay S Sato 2008 Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption Virology 371 1 121 129
54. M Ouellet S Mercier I Pelletier S Bounou J Roy J Hirabayashi S Sato MJ Tremblay 2005 Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells J Immunol 174 7 4120 4126